FGF23 effects on the heart-levels, time, source, and context matter.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 29933856.
- Also identified by DOI 10.1016/j.kint.2018.03.024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fibroblast growth factor 23 (FGF23) has appeared as a hormone that is massively elevated in patients with chronic kidney disease. Whether FGF23 is a risk factor that associates with cardiac pathologies and cardiovascular mortality, as suggested by a variety of clinical studies, or additionally acts as a causative factor that induces cardiac injury, as more recently indicated by cell culture and animal studies, is under debate and the center of many ongoing experimental studies.
Medical subject headings
- Cardiovascular Diseases
- Renal Insufficiency, Chronic